[ad_1]
Scientists from the University of Iowa have discovered that colicestocinine, a satiety hormone, helps reduce the risk of developing untreatable Alzheimer's disease.
According to the EurekAlert website, researchers have studied information from the results of 287 people with Alzheimer's disease
Euroimaging Initiative (ADNI), and found that the presence of satiety hormone in the small intestine contributes to the absorption of fats and proteins.
It has also been found that the risk of people with high levels of this hormone with cognitive impairment prior to Alzheimer's disease has decreased by 65%. When the toxic brain protein of Tao increases, the satiety hormone no longer affects memory disorders.
Scientists plan to study a diet that helps elevate the level of satiety in the human body. Because it will create a way to treat Alzheimer's disease or at least stop its development.
Source: Linta. Ro.
[ad_2]
Source link
